Literature DB >> 2443540

Defective antigen presentation and novel structural properties of DR1 from an HLA haplotype associated with 21-hydroxylase deficiency.

J E Davis1, R R Rich, M Van, H V Le, M S Pollack, R G Cook.   

Abstract

We have segregated DR1+ individuals into two categories according to whether or not their class II+ cells stimulated T lymphocyte clones specific for or restricted to DR1. In a majority of cases (87%), failure to stimulate was a property of cells having the B14;DR1 haplotype and/or nonclassical 21-hydroxylase deficiency. Absence of clonal proliferation could not be explained by release of an intercellular suppressor factor or by stimulator cell absorption of interleukin 2. Homozygous cells inheriting both stimulatory (DR1n) and nonstimulatory (DR1x) haplotypes did not successfully mediate clonal expansion, implying that a trans acting factor operates intracellularly to modify both DR1 alleles or their products. Other DR alleles did not appear to be affected as evidence by normal proliferative responses of T lymphocyte clones restricted to DR2 or DR7 and stimulated by DR1x,2 and DR1x,7 cells, respectively. By two-dimensional gel analysis, we have further identified a 50-kD surface glycoprotein contained in anti-DR immunoprecipitates of DR1x, but not DR1n or non-DR1 cellular lysates. This 50-kD structure had antigenic and peptide identity to DR alpha and beta chains but was resistant to dissociation under conditions that normally separate DR alpha and beta (8 M urea plus 5% 2-mercaptoethanol); boiling in sodium dodecyl sulfate was required to segregate the component polypeptides of the 50-kD heterodimer. We postulate that a product of a novel combinatorial association between constitutive chains of DR may interfere with or compete for normal T cell receptor recognition of DR1 as both an alloantigen and a restricting element. We further propose that gene abnormalities within the class III region of a haplotype associated with nonclassical 21-hydroxylase deficiency may extend into the DR subregion of the major histocompatibility complex with consequent aberrations in DR1 presentation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2443540      PMCID: PMC442338          DOI: 10.1172/JCI113194

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.

Authors:  P I TERASAKI; J D MCCLELLAND
Journal:  Nature       Date:  1964-12-05       Impact factor: 49.962

2.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

5.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

6.  Two populations of Ia-like molecules on a human B cell line.

Authors:  L A Lampson; R Levy
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

7.  Monoclonal antibodies to HLA--DRw determinants.

Authors:  F M Brodsky; P Parham; W F Bodmer
Journal:  Tissue Antigens       Date:  1980-07

8.  Cloning and functional characterization of primary alloreactive human T lymphocytes.

Authors:  J Kornbluth; B Dupont
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

9.  Human immune responses to hapten-conjugated cells. I. Primary and secondary proliferative responses in vitro.

Authors:  M F Seldin; R R Rich
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

10.  Continuous proliferation of murine antigen-specific helper T lymphocytes in culture.

Authors:  J Watson
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

View more
  3 in total

1.  Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3 in clinically healthy individuals.

Authors:  S Hashimoto; C C McCombs; J P Michalski
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

2.  Polymorphic Bgl II restriction sites of DR alpha demarcate a novel HLA-DR1 antigen.

Authors:  J E Davis; R G Cook; M Van; R R Rich
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

3.  Immunological pattern in patients with 21-hydroxylase deficiency.

Authors:  F Parlato; G Pisano; M Brillante; R Ferrone; M R Cavalcanti; E Cosentini; G Misiano; M Brai; A Bellastella
Journal:  J Endocrinol Invest       Date:  1994-09       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.